𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Flexibility and Function in HIV Protease: Dynamics of the HIV-1 Protease Bound to the Asymmetric Inhibitor Kynostatin 272 (KNI-272)

✍ Scribed by Freedberg, Darón I.; Wang, Yun-Xing; Stahl, Stephen J.; Kaufman, Joshua D.; Wingfield, Paul T.; Kiso, Yoshiaki; Torchia, Dennis A.

Book ID
126407025
Publisher
American Chemical Society
Year
1998
Tongue
English
Weight
123 KB
Volume
120
Category
Article
ISSN
0002-7863

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Conformational analysis of HIV-1 proteas
Conformational analysis of HIV-1 protease inhibitors: 2. Thioproline P1? Residue in the potent inhibitor KNI-272
✍ Murcko, Mark A.; Rao, B. Govinda; Gomperts, Roberto 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 2 views

does not contain a basic amine as do Saquinovir and JG-365, for example it should be easier to desolvate, which also assists in binding. The relationship between KNI-272, JG-365, Saquinovir, and P X proline-containing substrate also is 1

THE BIOAVAILABILITY OF ORAL DOSAGE FORMS
THE BIOAVAILABILITY OF ORAL DOSAGE FORMS OF A NEW HIV-1 PROTEASE INHIBITOR, KNI-272, IN BEAGLE DOGS
✍ A. Kiriyama; M. M. Sugahara; Y. Yoshikawa; Y. Kiso; K. Takada 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

The bioavailability (BA) of a tripeptide protease inhibitor, KNI-272, which has a strong pharmacological potential for treating human immunodeficiency virus type 1 (HIV-l), has been studied in beagle dogs by administering several oral dosage forms. The tested dosage forms were form 1, plain gelatin